Ecrins Therapeutics is a biotechnology company that focuses on the discovery and development of anti-cancer compounds. Its product ET-D5 is a small molecule active against several oncology indications. The company also has experience in drug discovery, medicinal chemistry, cell biology, and experimental oncology.